ECULIZUMAB IN SECONDARY ATYPICAL HEMOLYTIC UREMIC SYNDROME

被引：0
|
作者：
Cavero Escribano, Teresa [2 ]
Praga, Manuel [2 ]
de Cordoba, Santiago R. [1 ]
机构：
[1] CSIC, Ctr Invest Biomed Red Enfermedades, Raras Ctr Invest Biol, Madrid, Spain
[2] Hosp 12 Octubre, Nefrol, Madrid, Spain
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO036
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Rational use of eculizumab in secondary atypical hemolytic uremic syndrome
    Cordero, Lucia
    Cavero, Teresa
    Gutierrez, Eduardo
    Trujillo, Hernando
    Sandino, Justo
    Aunon, Pilar
    Rivero, Marta
    Morales, Enrique
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [2] Atypical hemolytic uremic syndrome secondary to lupus nephritis, responsive to eculizumab
    Raufi, Alexander G.
    Scott, Shruti
    Darwish, Omar
    Harley, Kevin
    Kahlon, Kanwarpal
    Desai, Sheetal
    Lu, Yuxin
    Minh-Ha Tran
    [J]. HEMATOLOGY REPORTS, 2016, 8 (03) : 44 - 47
  • [3] Eculizumab in Atypical Hemolytic-Uremic Syndrome
    Ring, Troels
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1377 - 1378
  • [4] Eculizumab cessation in atypical hemolytic uremic syndrome
    Merrill, Samuel A.
    Brittingham, Zachary D.
    Yuan, Xuan
    Moliterno, Alison R.
    Sperati, C. John
    Brodsky, Robert A.
    [J]. BLOOD, 2017, 130 (03) : 368 - 372
  • [5] ATYPICAL HEMOLYTIC UREMIC SYNDROME TREATED WITH ECULIZUMAB
    Khawar, M. U.
    Bhutta, U.
    Haragsim, L.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 410 - 410
  • [6] Eculizumab treatment of atypical hemolytic uremic syndrome
    Kaplan, Bernard S.
    Ruebner, Rebecca L.
    Copelovitch, Lawrence
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (02): : 167 - 176
  • [7] Eculizumab for Atypical Hemolytic Uremic Syndrome in Pregnancy
    Ardissino, Gianluigi
    Ossola, Manuela Wally
    Baffero, Giulia Maria
    Rigotti, Angelo
    Cugno, Massimo
    [J]. OBSTETRICS AND GYNECOLOGY, 2013, 122 (02): : 487 - 489
  • [8] SUCCESS OF ECULIZUMAB IN THE TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME
    Kantar, Asli
    Gulleroglu, Kaan
    Bayrakci, Umut
    Ozkaya, Ozan
    Ozcan, Ebru
    Baskin, Esra
    [J]. PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1572 - 1572
  • [9] Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome
    Mache, Christoph J.
    Acham-Roschitz, Birgit
    Fremeaux-Bacchi, Veronique
    Kirschfink, Michael
    Zipfel, Peter F.
    Roedl, Siegfried
    Vester, Udo
    Ring, Ekkehard
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (08): : 1312 - 1316
  • [10] The Importance of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome
    Santos, Mariana S.
    Ventura, Sofia
    Alves, Abel
    Cabral, Raquel
    Henriques, Manuela
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
12345